N-Telopeptides w/Creat COLLGN

Synonyms

Allscripts (AEHR) Order Name

N-Telopeptide Cross-link (NTx) Urine

Sunrise Clinical Manager (SCM) Order Name

N-Telopeptides w/Creatinine

EPIC Order Name

Urine N-Telopeptide Cross-links (NTx)

Clinical Info

Evaluation of osteoporosis and assessment of antiresorptive therapy

Specimen Type

Urine

Container

Urine-Yellow Top

Collection Instructions

Container/Tube: Sterile leak-proof container
Specimen:   20 mL from a second-morning urine collection.
                    Discard first-morning urine.
                   No preservative.(1 mL min)
Collection  Collect a second void of the morning (no preservative). When monitoring therapy, baseline samples should be collected prior to initiation of therapy. Subsequent specimens should be collected at the same time of day as baseline specimens.

Transport Instructions

Refrigerated

Specimen Stability

14 Days Room Temperature, Refrigerated, or Frozen

Methodology

Ortho Vitros Enhanced Chemiluminescence System

Days Performed

TAT: 4-6 Days

Performing Laboratory

LabCorp

CPT

82523 
82570  
 

PDM

5900486

Result Interpretation

Pediatric: see table.1
• Adults:
− Male: 0−62 nM BCE/mmol creatinine
− Female: 20 to 49 years 0−64 nM BCE/mmol creatinine; >49 years 0−89 nM BCE/mmol creatinine

 Pediatric: see table.1

• Adults:

− Male: 0−62 nM BCE/mmol creatinine

− Female: 20 to 49 years 0−64 nM BCE/mmol creatinine; >49 years 0−89 nM BCE/mmol creatinine

Tanner Stage

Male

(nM BCE/mmol creatinine)

Female

(nM BCE/mmol creatinine)

I

55−508

6−662

II

21−423

193−514

III

27−462

13−632

IV

<609

<389

V

<240

<132


 
 

Forms


edit